Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice. - Wikidata - wikimedia - TriplyDB

Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice.

Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice.

http://www.wikidata.org/entity/Q37219748

about

The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.Virus-like particles: flexible platforms for vaccine development.Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.Serological relationship between cutaneous human papillomavirus types 5, 8 and 92 Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy.AD vaccines: conclusions and future directions.Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Vaccination as a therapeutic approach to Alzheimer's disease.Murine models of Alzheimer's disease and their use in developing immunotherapies.Antigen delivery by virus-like particles for immunotherapeutic vaccination.The application of virus-like particles as vaccines and biological vehicles.Virus-based nanoparticles as platform technologies for modern vaccines.Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.Distinct Immunologic Properties of Soluble Versus Particulate Antigens.

P2860

Q35183183-8BE20E96-3E67-4DED-ABAF-0EF149A71035 Q36837144-C2618D06-86D3-435A-BC04-08244C555621 Q36919081-07FB604A-48FD-49CB-97DB-AFA576E3B1C6 Q37219730-BB3298B5-4603-4AE2-A5B0-4DC42BC2D2A9 Q37226380-1E364157-23AB-483C-A83A-B3D93DEDC2C4 Q37306139-43635C00-144B-48EA-B33F-41996C096E8C Q37356046-762597C3-4D11-43E8-86E9-22F5B2F61DDE Q37438261-37429A2B-5C3F-40EE-8385-5EA2C73E366E Q37438273-D3AF829A-52AE-4575-AD1D-B23089B4478B Q37461092-06AD9E49-FC5D-44D7-9C6C-769EEA84E9F9 Q37604412-7247429A-D7D4-48D9-BF77-DAE09BAD9CAE Q37655247-5E6C2835-4FB9-4B05-A512-CD898A31B22A Q37681432-4193ABB0-22AC-4BBE-9438-188407D43FF6 Q37752915-CA2105B7-BC16-4418-B4B8-EDD9303D84F6 Q38285854-88EDBC04-B0F9-4C5C-B291-51C053D13587 Q38603912-C0BEE161-F3C2-4CF1-8FEA-26A51B0C09DA Q38702017-1652E231-370A-413C-92F0-9B565FCE9DAD Q42610772-C4C77B74-E87E-43E0-87FD-35E3DF81AE4E Q45325394-0BFA55B1-BCCA-4421-87E4-C3863070A534 Q51481172-AE9A19D1-5E5A-41A9-BDC2-A05CFF72914D Q55270638-6C6FFB92-06BE-451D-BF2C-EAAC76C5AD76

P2860

Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice.

http://www.wikidata.org/entity/Q37219748

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@en

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@nl

type

label

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@en

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@nl

prefLabel

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@en

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@nl

P1433

Q37219748-9611B138-6FAF-492E-9371-51B3E89E793F

P1476

Q37219748-2C9B7938-D16B-440A-92A2-2C69FC9EBBB9

P2093

Q37219748-0A2AA6E5-630F-4028-A728-178BFF917379

Q37219748-0C080B7C-EE9D-4442-9E7C-84458C0323DF

Q37219748-2257D8A8-4061-4AD3-8F24-CF1C30F85CAD

Q37219748-37D706E0-CB81-432C-A079-9FAA23F7435E

Q37219748-8076D846-492C-453C-8AB6-83FDC562DD61

Q37219748-B8FD5E12-4A0E-4157-B721-83CE3EC2659B

Q37219748-C11C549E-B869-4B54-95F2-3559C86C418C

Q37219748-D25C271F-6A6F-4B69-AFDD-4F17A39EC180

Q37219748-FF2B14D6-4348-4B3E-9503-7A2140707D03

P2860

Q37219748-026C8F4C-D60E-4FD8-87E5-43314B5EB10F

Q37219748-137109DA-22CA-405B-B479-7213DAF5293B

Q37219748-1AB93BDB-CFEA-4589-9EC6-E42741A9C640

Q37219748-1B2DED22-02DF-4981-9EBE-FE07BE00FFF6

Q37219748-1B937B7C-2EA8-4C1B-A018-13330142DA9C

Q37219748-1E93501E-7776-419B-AB51-BF9054BA5671

Q37219748-220A24C8-D087-4A10-94DD-FF5463E57D27

Q37219748-27D19323-EF99-4011-86F7-47A8157BCB3D

Q37219748-281BCAAB-5A75-4DD5-9401-A0104E7F6938

Q37219748-28ECDFAE-C392-4994-89CB-DF6667CCB254

P304

Q37219748-CDB162E0-C8B1-4019-A1E6-9C9EE861ED3A

P31

Q37219748-F29E36D1-016C-451C-838F-0672A2E24406

P356

Q37219748-ABC5E7D7-FCEE-446B-89F1-1028D371962D

P407

Q37219748-7F998BD2-ACC4-428B-90E3-9C4E918D30D2

P433

Q37219748-A33755F1-8222-4705-8EB3-BA25C24AFB3D

P478

Q37219748-08A734CA-F0BF-458A-B33A-39879D808FA3

P577

Q37219748-2781487E-555D-47F0-9CD0-4083DF9CCA49

P5875

Q37219748-8276B950-1CF8-4680-B437-0DDE0AB31F6D

P698

Q37219748-5016285D-E4BD-4DDB-A299-DF0782BF6DA1

P921

Q37219748-A84C74EF-726A-4B7D-8C9C-4055A2159B07

P932

Q37219748-03B64D31-0927-4BAF-ACA9-B3C6CEFB98CB

P356

JIMMUNOL.177.4.2662

P1433

Journal of Immunology

P1476

Papillomavirus-like particles ...... n rabbits and transgenic mice.

@en

P2093

Alessandra Handisurya

http://www.w3.org/2001/XMLSchema#string

Christopher Cox

http://www.w3.org/2001/XMLSchema#string

David Borchelt

http://www.w3.org/2001/XMLSchema#string

Eduardo Zamora

http://www.w3.org/2001/XMLSchema#string

Gay Rudow

http://www.w3.org/2001/XMLSchema#string

Juan C Troncoso

http://www.w3.org/2001/XMLSchema#string

Katherine Conant

http://www.w3.org/2001/XMLSchema#string

Reinhard Kirnbauer

http://www.w3.org/2001/XMLSchema#string

Saeed Shafti-Keramat

http://www.w3.org/2001/XMLSchema#string

P2860

Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

Molecular mimicry between non-self, modified self and self in autoimmunity

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction.

beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

P304

2662-2670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.177.4.2662

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6898856

http://www.w3.org/2001/XMLSchema#string

P698

16888028

http://www.w3.org/2001/XMLSchema#string

P921

P932

3792340

http://www.w3.org/2001/XMLSchema#string